Drug Profile
Research programme: GABA A receptor agonists - Neurogen Corporation
Alternative Names: NG2-83Latest Information Update: 06 Jul 2010
Price :
$50
*
At a glance
- Originator Neurogen Corporation
- Developer Ligand Pharmaceuticals
- Class
- Mechanism of Action GABA A alpha 3 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Anxiety disorders
Most Recent Events
- 06 Jul 2010 Development discontinued during 2008